BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020;134:104700. [PMID: 31809788 DOI: 10.1016/j.nbd.2019.104700] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Sun X, Xue L, Wang Z, Xie A. Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism. Front Neurosci 2022;16:878239. [PMID: 35873830 DOI: 10.3389/fnins.2022.878239] [Reference Citation Analysis]
2 Wang J, Yang X, Zeng W, Zhang X, Yang X, Xu Y, Liu K, Zhang Z, Xu Y, Cao X. Dual Effects: Intrastriatal Injection of α-syn N103/tau N368 Preformed Fibrils Promotes Endogenous α-synuclein Aggregates in the Proximal Colon. J Parkinsons Dis 2022. [PMID: 35912751 DOI: 10.3233/JPD-223294] [Reference Citation Analysis]
3 Lahuerta-martín S, Llamas-ramos R, Llamas-ramos I. Effectiveness of Therapies Based on Mirror Neuron System to Treat Gait in Patients with Parkinson’s Disease—A Systematic Review. JCM 2022;11:4236. [DOI: 10.3390/jcm11144236] [Reference Citation Analysis]
4 Li X, Wei W, Wang Y, Wang Q, Liu Z. Global Trend in the Research and Development of Acupuncture Treatment on Parkinson's Disease From 2000 to 2021: A Bibliometric Analysis. Front Neurol 2022;13:906317. [DOI: 10.3389/fneur.2022.906317] [Reference Citation Analysis]
5 Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol 2022:S1044-579X(22)00155-9. [PMID: 35779712 DOI: 10.1016/j.semcancer.2022.06.011] [Reference Citation Analysis]
6 Fadil R, Huether AXA, Verma AK, Brunnemer R, Blaber AP, Lou J, Tavakolian K. Effect of Parkinson’s Disease on Cardio-postural Coupling During Orthostatic Challenge. Front Physiol 2022;13:863877. [DOI: 10.3389/fphys.2022.863877] [Reference Citation Analysis]
7 Stoco-Oliveira MC, Valente HB, Vanzella LM, André LB, Rodrigues MV, Vanderlei FM, Carvalho AC, Vanderlei LCM. Does length of time since diagnosis in Parkinson's disease influence heart rate variability? A cross-sectional study. Arq Neuropsiquiatr 2022:S0004-282X2022005010201. [PMID: 35613209 DOI: 10.1590/0004-282X-ANP-2021-0153] [Reference Citation Analysis]
8 Xiao Y, Chen H, Liao J, Zhang Q, He H, Lei J, Huang J, Ouyang Q, Shen Y, Wang J. The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease. Front Neurosci 2022;16:893713. [DOI: 10.3389/fnins.2022.893713] [Reference Citation Analysis]
9 Campo-Prieto P, Cancela-Carral JM, Rodríguez-Fuentes G. Wearable Immersive Virtual Reality Device for Promoting Physical Activity in Parkinson's Disease Patients. Sensors (Basel) 2022;22:3302. [PMID: 35590992 DOI: 10.3390/s22093302] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Fujita H, Shiina T, Sakuramoto H, Nozawa N, Ogaki K, Suzuki K. Sleep and Autonomic Manifestations in Parkinson’s Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder. Front Neurosci 2022;16:874349. [DOI: 10.3389/fnins.2022.874349] [Reference Citation Analysis]
11 Satarker S, Bojja SL, Gurram PC, Mudgal J, Arora D, Nampoothiri M. Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders. Cells 2022;11:1139. [PMID: 35406702 DOI: 10.3390/cells11071139] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Safarpour D, Sharzehi K, Pfeiffer RF. Gastrointestinal Dysfunction in Parkinson’s Disease. Drugs. [DOI: 10.1007/s40265-021-01664-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Han MN, Finkelstein DI, Mcquade RM, Diwakarla S. Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics. JPM 2022;12:144. [DOI: 10.3390/jpm12020144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhang XL, Zhang XH, Yu X, Zheng LF, Feng XY, Liu CZ, Quan ZS, Zhang Y, Zhu JX. Enhanced Contractive Tension and Upregulated Muscarinic Receptor 2/3 in Colorectum Contribute to Constipation in 6-Hydroxydopamine-Induced Parkinson's Disease Rats. Front Aging Neurosci 2021;13:770841. [PMID: 35002677 DOI: 10.3389/fnagi.2021.770841] [Reference Citation Analysis]
15 Horsager J, Knudsen K, Sommerauer M. Clinical and imaging evidence of brain-first and body-first Parkinson's disease. Neurobiol Dis 2022;:105626. [PMID: 35031485 DOI: 10.1016/j.nbd.2022.105626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
16 Torres-Yaghi Y, Carwin A, Carolan J, Nakano S, Amjad F, Pagan F. QTc Interval Prolongation with Therapies Used to Treat Patients with Parkinson's Disease Psychosis: A Narrative Review. Neuropsychiatr Dis Treat 2021;17:3791-818. [PMID: 34992373 DOI: 10.2147/NDT.S324145] [Reference Citation Analysis]
17 Nasri A, Kacem I, Farhat N, Gharbi A, Sakka S, Souissi A, Zidi S, Damak M, Bendjebara M, Gargouri A, Mhiri C, Gouider R. Heart rate variability and sympathetic skin response for the assessment of autonomic dysfunction in leucine-rich repeat kinase 2 associated Parkinson's disease. Neurophysiologie Clinique 2022. [DOI: 10.1016/j.neucli.2021.12.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gerasimova-Meigal L, Meigal A, Sireneva N, Saenko I. Autonomic Function in Parkinson's Disease Subjects Across Repeated Short-Term Dry Immersion: Evidence From Linear and Non-linear HRV Parameters. Front Physiol 2021;12:712365. [PMID: 34690794 DOI: 10.3389/fphys.2021.712365] [Reference Citation Analysis]
19 Chu C, Yu L, Chen W, Tian F, Zhai Q. Dietary patterns affect Parkinson's disease via the microbiota-gut-brain axis. Trends in Food Science & Technology 2021;116:90-101. [DOI: 10.1016/j.tifs.2021.07.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 You S, Hong JH, Yoo J. Analysis of pupillometer results according to disease stage in patients with Parkinson's disease. Sci Rep 2021;11:17880. [PMID: 34504251 DOI: 10.1038/s41598-021-97599-4] [Reference Citation Analysis]
21 Komici K, Femminella GD, Bencivenga L, Rengo G, Pagano G. Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses. J Parkinsons Dis 2021;11:1585-96. [PMID: 34486987 DOI: 10.3233/JPD-212725] [Reference Citation Analysis]
22 Zhou Y, Zhao WJ, Quan W, Qiao CM, Cui C, Hong H, Shi Y, Niu GY, Zhao LP, Shen YQ. Dynamic changes of activated AHR in microglia and astrocytes in the substantia nigra-striatum system in an MPTP-induced Parkinson's disease mouse model. Brain Res Bull 2021;176:174-83. [PMID: 34478811 DOI: 10.1016/j.brainresbull.2021.08.013] [Reference Citation Analysis]
23 Guilherme EM, Moreira RFC, de Oliveira A, Ferro AM, Di Lorenzo VAP, Gianlorenço ACL. Respiratory Disorders in Parkinson's Disease. J Parkinsons Dis 2021;11:993-1010. [PMID: 33780376 DOI: 10.3233/JPD-212565] [Reference Citation Analysis]
24 Natale G, Ryskalin L, Morucci G, Lazzeri G, Frati A, Fornai F. The Baseline Structure of the Enteric Nervous System and Its Role in Parkinson's Disease. Life (Basel) 2021;11:732. [PMID: 34440476 DOI: 10.3390/life11080732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Santos-García D, de Deus T, Cores C, Canfield H, Paz González JM, Martínez Miró C, Valdés Aymerich L, Suárez E, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández-Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, Nogueira V, Puente V, Dotor J, Borrué C, Solano B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo F, Martínez Castrillo JC, Sánchez Alonso P, Alonso G, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, Ardura J, Alonso R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P, Coppadis Study Group. Predictors of Global Non-Motor Symptoms Burden Progression in Parkinson's Disease. Results from the COPPADIS Cohort at 2-Year Follow-Up. J Pers Med 2021;11:626. [PMID: 34209166 DOI: 10.3390/jpm11070626] [Reference Citation Analysis]
26 Vargas Garcia MA, Cely Arboleda A, Suarez JT, Vélez Gutiérrez DA. Clasificación Del Nivel De Riesgo Por Errores Funcionales de la Deglución (CRAF). Rev Areté 2021;21:77-85. [DOI: 10.33881/1657-2513.art.21107] [Reference Citation Analysis]
27 Vargas Garcia MA, Cely Arboleda A, Suarez JT, Vélez Gutiérrez DA. Clasificación Del Nivel De Riesgo Por Errores Funcionales de la Deglución (CRAF). Rev Areté 2021;21:77-85. [DOI: 10.33881/1657-2513.art21107] [Reference Citation Analysis]
28 Vargas Garcia MA, Bustamante Arboleda V, Ospina Ruiz A, Valvuena Cuartas C. Abordaje Rehabilitador de la Deglución en Adultos Mayores con Enfermedades Neurodegenerativas: Revisión Sistemática: Revisión sistemática. Rev Areté 2021;21:55-64. [DOI: 10.33881/1657-2513.art21105] [Reference Citation Analysis]
29 Vargas Garcia MA, Bustamante Arboleda V, Ospina Ruiz A, Valvuena Cuartas C. Abordaje Rehabilitador de la Deglución en Adultos Mayores con Enfermedades Neurodegenerativas: Revisión Sistemática: Revisión sistemática. Rev Areté 2021;21:55-64. [DOI: 10.33881/1657-2513.art.21105] [Reference Citation Analysis]
30 Kasap M, Dwyer DS. Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease. J Neural Transm (Vienna) 2021;128:749-62. [PMID: 33961117 DOI: 10.1007/s00702-021-02348-6] [Reference Citation Analysis]
31 Wang H, Fang B, Peng B, Wang L, Xue Y, Bai H, Lu S, Voelcker NH, Li L, Fu L, Huang W. Recent Advances in Chemical Biology of Mitochondria Targeting. Front Chem 2021;9:683220. [PMID: 34012953 DOI: 10.3389/fchem.2021.683220] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 McQuade RM, Singleton LM, Wu H, Lee S, Constable R, Di Natale M, Ringuet MT, Berger JP, Kauhausen J, Parish CL, Finkelstein DI, Furness JB, Diwakarla S. The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease. Sci Rep 2021;11:7934. [PMID: 33846426 DOI: 10.1038/s41598-021-86917-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Steinbach MJ, Campbell RW, DeVore BB, Harrison DW. Laterality in Parkinson's disease: a neuropsychological review. Appl Neuropsychol Adult 2021;:1-15. [PMID: 33844619 DOI: 10.1080/23279095.2021.1907392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Harms AS, Ferreira SA, Romero-Ramos M. Periphery and brain, innate and adaptive immunity in Parkinson's disease. Acta Neuropathol 2021;141:527-45. [PMID: 33555429 DOI: 10.1007/s00401-021-02268-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 39.0] [Reference Citation Analysis]
35 Mitchell SD, Sidiropoulos C. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review. Toxins (Basel) 2021;13:226. [PMID: 33808714 DOI: 10.3390/toxins13030226] [Reference Citation Analysis]
36 Navarro-Zaragoza J, Cuenca-Bermejo L, Almela P, Laorden ML, Herrero MT. Could Small Heat Shock Protein HSP27 Be a First-Line Target for Preventing Protein Aggregation in Parkinson's Disease? Int J Mol Sci 2021;22:3038. [PMID: 33809767 DOI: 10.3390/ijms22063038] [Reference Citation Analysis]
37 Ponsi G, Scattolin M, Villa R, Aglioti SM. Human moral decision-making through the lens of Parkinson's disease. NPJ Parkinsons Dis 2021;7:18. [PMID: 33654110 DOI: 10.1038/s41531-021-00167-w] [Reference Citation Analysis]
38 Rukavina K, Batzu L, Boogers A, Abundes-Corona A, Bruno V, Chaudhuri KR. Non-motor complications in late stage Parkinson's disease: recognition, management and unmet needs. Expert Rev Neurother 2021;21:335-52. [PMID: 33522312 DOI: 10.1080/14737175.2021.1883428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Gonçalves VC, Cuenca-Bermejo L, Fernandez-Villalba E, Martin-Balbuena S, da Silva Fernandes MJ, Scorza CA, Herrero MT. Heart Matters: Cardiac Dysfunction and Other Autonomic Changes in Parkinson's Disease. Neuroscientist 2021;:1073858421990000. [PMID: 33583239 DOI: 10.1177/1073858421990000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Ashraf-Ganjouei A, Moradi K, Aarabi M, Abdolalizadeh A, Kazemi SZ, Kasaeian A, Vahabi Z. The Association Between REM Sleep Behavior Disorder and Autonomic Dysfunction in Parkinson's Disease. J Parkinsons Dis 2021;11:747-55. [PMID: 33579870 DOI: 10.3233/JPD-202134] [Reference Citation Analysis]
41 Sun J, He C, Yan QX, Wang HD, Li KX, Sun X, Feng Y, Zha RR, Cui CP, Xiong X, Gao S, Wang X, Yin RX, Qiao GF, Li BY. Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats. CNS Neurosci Ther 2021;27:540-51. [PMID: 33475253 DOI: 10.1111/cns.13589] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Tarianyk KA, Lytvynenko NV, Shkodina AD, Kaidashev IP. THE ROLE OF CIRCADIAN REGULATION OF GHRELIN LEVELS IN PARKINSON’S DISEASE (LITERATURE REVIEW). Wiad Lek 2021;74:1750-3. [DOI: 10.36740/wlek202107132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Marinescu I, Marinescu D, Mogoantă L, Efrem IC, Stovicek PO. SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine. Rom J Morphol Embryol 2020;61:1007-22. [PMID: 34171050 DOI: 10.47162/RJME.61.4.03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Ernsberger U, Deller T, Rohrer H. The diversity of neuronal phenotypes in rodent and human autonomic ganglia. Cell Tissue Res 2020;382:201-31. [PMID: 32930881 DOI: 10.1007/s00441-020-03279-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Santiago JE, Cameron AP, Navarrete RA. Addressing Sphincter Dysfunction in the Female with Neurogenic Lower Urinary Tract Dysfunction. Curr Bladder Dysfunct Rep 2020;15:142-52. [DOI: 10.1007/s11884-020-00597-x] [Reference Citation Analysis]
46 Sun Y, Kamat A, Singh BB. Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells. Front Physiol 2020;11:305. [PMID: 32390858 DOI: 10.3389/fphys.2020.00305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]